Strata Critical Medical (SRTA) Equity Average (2019 - 2026)

Strata Critical Medical has disclosed Equity Average across 8 years of filings, most recently posting $282.4 million for Q1 2026.

• In Q1 2026, Equity Average rose 27.88% year-over-year to $282.4 million; the TTM figure through Mar 2026 stood at $282.4 million (up 27.88% YoY), while the FY2025 annual figure was $250.5 million, up 9.81% from the prior year.
• Equity Average steadied at $282.4 million in Q1 2026, from $281.0 million in the prior quarter.
• Over the last five years, Equity Average for SRTA reached as high as $287.5 million in Q3 2022 and fell as low as $220.8 million in Q1 2025.
• The 5-year median for Equity Average is $261.8 million (2023), against an average of $257.3 million.
• Annual changes were most pronounced in 2022 — Equity Average soared 3137.85% — and 2024, when it fell 13.55%.
• A 5-year view of Equity Average shows it stood at $278.6 million in 2022, then slipped by 10.77% to $248.6 million in 2023, then dropped by 8.4% to $227.7 million in 2024, then rose by 23.41% to $281.0 million in 2025, then gained by 0.49% to $282.4 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $282.4 million, $281.0 million, and $253.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.